We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Cervical Cancer Screening Should Continue after 65

By HospiMedica International staff writers
Posted on 18 May 2017
Print article
Image: The Pap test is the most common form of cervical screening (Photo courtesy of Alamy).
Image: The Pap test is the most common form of cervical screening (Photo courtesy of Alamy).
A new study suggests that women without a hysterectomy and women over 65 who have not been recently screened may benefit from continued surveillance for cervical cancer (CC).

Researchers at the U.S. Centers for Disease Control and Prevention conducted a study that examined recent CC incidence data from the U.S. 2013 and 2015 National Health Interview Survey (NHIS) federal cancer surveillance programs for all women by age and race, corrected for hysterectomy status. They then calculated the proportion of women aged 41–70 years without a hysterectomy who reported that they never had a Papanicolaou (Pap) test or that their most recent Pap test was at least five years previously.

The results revealed that when corrected for hysterectomy, incidence rates of CC increased with age until 70 years, and did not begin to decline until age 85. In addition, many women approaching the accepted "stopping" age of 65 were not getting sufficient screening, and that the proportion of women not recently screened increases with age. While only 12% of women in their 40s had no recent screening history, that number progressively increased for women in their 50s and 60s. Nearly 850,000 women aged 61-65 years had not been screened within the last five years. The study was published on May 1, 2017, in the American Journal of Preventive Medicine.

“A recommended upper age limit for routine screening may lead women and providers to assume that cervical cancer is a younger women's disease. After adjustment for hysterectomy, some of the highest cervical cancer incidence rates occur among women older than 65 years, with notably higher rates among older black women,” said lead author epidemiologist Mary White, ScD, of the Division of Cancer Prevention and Control at the CDC. “Women who have not had a hysterectomy need to continue to be screened until age 65, and possibly later if they have not been screened for many years or are at special risk.

Cervical cancer arises from the cervix; it typically develops from precancerous changes over 10-20 years. Symptoms may include abnormal vaginal bleeding, pelvic pain, or pain during sexual intercourse. Human papillomavirus (HPV) infection causes more than 90% of cases, with other risk factors include smoking, a weak immune system, birth control pills, many sexual partners, and starting sex at a young age. CC diagnosis is typically by cervical screening followed by a biopsy.

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Display
i3 Series

Print article

Channels

Surgical Techniques

view channel
Image: The wearable technology assesses surgeons’ posture during surgery (Photo courtesy of Baylor College of Medicine)

Wearable Technology Monitors and Analyzes Surgeons' Posture during Long Surgical Procedures

The physical strain associated with the static postures maintained by neurosurgeons during long operations can lead to fatigue and musculoskeletal problems. An objective assessment of surgical ergonomics... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.